
    
      Subjects will check-in on Day -1 and remain confined to the clinical unit until Day 13. On
      the morning of Day 1, subjects will receive a single dose of dextromethorphan. On Days 6 and
      7, subjects will receive isavuconazole three times daily (TID) administered approximately 8
      hours apart. On Day 8 through 12, subjects will receive isavuconazole once daily (QD). On Day
      10, subjects will receive a single dose of dextromethorphan. A follow-up visit will be
      scheduled on Day 21 (Â± 2 days).
    
  